[HTML][HTML] The first 12 months of COVID-19: a timeline of immunological insights

T Carvalho, F Krammer, A Iwasaki - Nature Reviews Immunology, 2021 - nature.com
Since the initial reports of a cluster of pneumonia cases of unidentified origin in Wuhan,
China, in December 2019, the novel coronavirus that causes this disease—severe acute …

Immunity, endothelial injury and complement-induced coagulopathy in COVID-19

L Perico, A Benigni, F Casiraghi, LFP Ng… - Nature Reviews …, 2021 - nature.com
In December 2019, a novel coronavirus was isolated from the respiratory epithelium of
patients with unexplained pneumonia in Wuhan, China. This pathogen, named severe acute …

A systematic review of SARS-CoV-2 vaccine candidates

Y Dong, T Dai, Y Wei, L Zhang, M Zheng… - Signal transduction and …, 2020 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging virus that is
highly pathogenic and has caused the recent worldwide pandemic officially named …

A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics

L Si, H Bai, M Rodas, W Cao, CY Oh, A Jiang… - Nature biomedical …, 2021 - nature.com
The rapid repurposing of antivirals is particularly pressing during pandemics. However,
rapid assays for assessing candidate drugs typically involve in vitro screens and cell lines …

Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence

S Rahman, MTV Montero, K Rowe… - Expert review of …, 2021 - Taylor & Francis
Introduction The COVID-19 pandemic has created a public health crisis, infected millions of
people, and caused a significant number of deaths. SARS-CoV-2 transmits from person to …

Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)

AR Bourgonje, AE Abdulle, W Timens… - The Journal of …, 2020 - Wiley Online Library
Abstract Angiotensin‐converting enzyme 2 (ACE2) has been established as the functional
host receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus …

[HTML][HTML] Role of mass media and public health communications in the COVID-19 pandemic

A Anwar, M Malik, V Raees, A Anwar - Cureus, 2020 - ncbi.nlm.nih.gov
In Dec 2019, a novel pathogen emerged, and within weeks, led to the emergence of the
biggest global health crises seen to date. The virus called 'SARS-CoV-2', causes …

An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies

HF Tsang, LWC Chan, WCS Cho, ACS Yu… - Expert review of anti …, 2021 - Taylor & Francis
Introduction To date, the transmission of Coronavirus Disease-2019 (COVID-19) is still
uncontrollable with the fact that the numbers of confirmed and death cases are still …

Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management

B Siripanthong, S Nazarian, D Muser, R Deo… - Heart rhythm, 2020 - Elsevier
Human coronavirus-associated myocarditis is known, and a number of coronavirus disease
19 (COVID-19)–related myocarditis cases have been reported. The pathophysiology of …

Drug treatments for covid-19: living systematic review and network meta-analysis

RAC Siemieniuk, JJ Bartoszko, D Zeraatkar, E Kum… - bmj, 2020 - bmj.com
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …